4.7 Article

Galectin-1 Cooperates with Yersinia Outer Protein (Yop) P to Thwart Protective Immunity by Repressing Nitric Oxide Production

期刊

BIOMOLECULES
卷 11, 期 11, 页码 -

出版社

MDPI
DOI: 10.3390/biom11111636

关键词

Yersinia enterocolitica; YopP; Galectin-1; nitric oxide; macrophages

资金

  1. Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP 00815]
  2. Universidad Nacional de San Luis [PROICO 2-1218]
  3. Fundacion Sales
  4. Fundacion Bunge y Born

向作者/读者索取更多资源

Galactin-1 (Gal1) binds to Yops in a carbohydrate-dependent manner, protecting them from trypsin digestion. Gal1 and YopP cooperatively inhibit nitric oxide (NO) production, without influencing other inflammatory mediators. In Yersinia enterocolitica infection, Gal1 and YopP play a coordinated role in modulating macrophage function.
Yersinia enterocolitica (Ye) inserts outer proteins (Yops) into cytoplasm to infect host cells. However, in spite of considerable progress, the mechanisms implicated in this process, including the association of Yops with host proteins, remain unclear. Here, we evaluated the functional role of Galectin-1 (Gal1), an endogenous beta-galactoside-binding protein, in modulating Yop interactions with host cells. Our results showed that Gal1 binds to Yops in a carbohydrate-dependent manner. Interestingly, Gal1 binding to Yops protects these virulence factors from trypsin digestion. Given that early control of Ye infection involves activation of macrophages, we evaluated the role of Gal1 and YopP in the modulation of macrophage function. Although Gal1 and YopP did not influence production of superoxide anion and/or TNF by Ye-infected macrophages, they coordinately inhibited nitric oxide (NO) production. Notably, recombinant Gal1 (rGal1) did not rescue NO increase observed in Lgals1(-/-) macrophages infected with the YopP mutant Ye increment yopP. Whereas NO induced apoptosis in macrophages, no significant differences in cell death were detected between Gal1-deficient macrophages infected with Ye increment yopP, and WT macrophages infected with Ye wt. Strikingly, increased NO production was found in WT macrophages treated with MAPK inhibitors and infected with Ye wt. Finally, rGal1 administration did not reverse the protective effect in Peyer Patches (PPs) of Lgals1(-/-) mice infected with Ye increment yopP. Our study reveals a cooperative role of YopP and endogenous Gal1 during Ye infection.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemistry & Molecular Biology

Dual knockdown of Galectin-8 and its glycosylated ligand, the activated leukocyte cell adhesion molecule (ALCAM/CD166), synergistically delays in vivo breast cancer growth

Fatima Ferragut, Alejandro J. Cagnoni, Lucas L. Colombo, Clara Sanchez Terrero, Carlota Wolfenstein-Todel, Maria F. Troncoso, Silvia I. Vanzulli, Gabriel A. Rabinovich, Karina V. Marino, Maria T. Elola

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2019)

Article Biochemical Research Methods

Immunoglobulin A N-glycosylation Presents Important Body Fluid-specific Variations in Lactating Mothers

Elisha Goonatilleke, Jennifer T. Smilowitz, Karina Marino, Bruce J. German, Carlito B. Lebrilla, Mariana Barboza

MOLECULAR & CELLULAR PROTEOMICS (2019)

Article Biochemistry & Molecular Biology

An adipose tissue galectin controls endothelial cell function via preferential recognition of 3-fucosylated glycans

Sebastian M. Maller, Alejandro J. Cagnoni, Nadia Bannoud, Lorena Sigaut, Juan M. Perez Saez, Lia I. Pietrasanta, Ri-Yao Yang, Fu-Tong Liu, Diego O. Croci, Santiago Di Lella, Victoria Sundblad, Gabriel A. Rabinovich, Karina V. Marino

FASEB JOURNAL (2020)

Review Biochemistry & Molecular Biology

Full-length galectin-8 and separate carbohydrate recognition domains: the whole is greater than the sum of its parts?

Alejandro J. Cagnoni, Maria F. Troncoso, Gabriel A. Rabinovich, Karina V. Marino, Maria T. Elola

BIOCHEMICAL SOCIETY TRANSACTIONS (2020)

Editorial Material Chemistry, Multidisciplinary

Editorial: Addressing Roles for Glycans in Immunology Using Chemical Biology

Matthew S. Macauley, Christoph Rademacher, Karina V. Marino

FRONTIERS IN CHEMISTRY (2020)

Article Biochemical Research Methods

Crystal structures of peanut lectin in the presence of synthetic β-N- and β-S-galactosides disclose evidence for the recognition of different glycomimetic ligands

Alejandro J. Cagnoni, Emiliano D. Primo, Sebastian Klinke, Maria E. Cano, Walter Giordano, Karina V. Marino, Jose Kovensky, Fernando A. Goldbaum, Maria Laura Uhrig, Lisandro H. Otero

ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2020)

Article Biochemistry & Molecular Biology

Spatiotemporal regulation of galectin-1-induced T-cell death in lamina propria from Crohn's disease and ulcerative colitis patients

Rodrigo Papa-Gobbi, Cecilia I. Muglia, Andres Rocca, Renata Curciarello, Alicia M. Sambuelli, Martin Yantorno, Gustavo Correa, Luciano G. Morosi, Antonio Di Sabatino, Paolo Biancheri, Thomas T. MacDonald, Marta A. Toscano, Karina V. Marino, Gabriel A. Rabinovich, Guillermo H. Docena

Summary: The study found that transient regulation of O-glycan profile during inflammation modulates Gal-1 binding and LP T-cell survival in IBD patients.

APOPTOSIS (2021)

Article Multidisciplinary Sciences

Galectin-1 fosters an immunosuppressive microenvironment in colorectal cancer by reprogramming CD8(+) regulatory T cells

Alejandro J. Cagnoni, Maria Laura Giribaldi, Ada G. Blidner, Anabela M. Cutine, Sabrina G. Gatto, Rosa M. Morales, Mariana Salatino, Martin C. Abba, Diego O. Croci, Karina V. Marino, Gabriel A. Rabinovich

Summary: Colorectal cancer is a common malignancy with limited response to immunotherapy, prompting the need for new biomarkers and therapeutic targets. Gal-1, as an endogenous glycan-binding protein, has been found to influence the activity of CD8(+) regulatory T cells in CRC, suggesting a potential immunotherapeutic approach for this disease.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Article Immunology

Hypoxia Supports Differentiation of Terminally Exhausted CD8 T Cells

Nadia Bannoud, Tomas Dalotto-Moreno, Lucia Kindgard, Pablo A. Garcia, Ada G. Blidner, Karina V. Marino, Gabriel A. Rabinovich, Diego O. Croci

Summary: This study highlights the reciprocal regulation between hypoxia, angiogenesis, and immunosuppression in tumor progression and anti-tumor therapies. The findings suggest a rational basis for optimizing synergistic combinations of antiangiogenic and immunotherapeutic strategies to enhance treatment efficacy.

FRONTIERS IN IMMUNOLOGY (2021)

Article Biochemistry & Molecular Biology

Structural insights in galectin-1-glycan recognition: Relevance of the glycosidic linkage and the N-acetylation pattern of sugar moieties

Cecilia Porciuncula-Gonzalez, Alejandro J. Cagnoni, Carolina Fontana, Karina Marino, Patricia Saenz-Mendez, Cecilia Giacomini, Gabriela Irazoqui

Summary: This study evaluated the binding affinity of Gal-1 for various galactosides, showing weaker affinity for beta-(1->6) galactosides compared to beta-(1->4) and beta-(1->3) galactosides. Docking experiments revealed key interactions between Gal-1 and specific amino acid residues of evaluated galactosides, contributing to the understanding of galectin-glycan affinity.

BIOORGANIC & MEDICINAL CHEMISTRY (2021)

Article Multidisciplinary Sciences

Control of intestinal inflammation by glycosylation-dependent lectin-driven immunoregulatory circuits

Luciano G. Morosi, Anabela M. Cutine, Alejandro J. Cagnoni, Montana N. Manselle-Cocco, Diego O. Croci, Joaquin P. Merlo, Rosa M. Morales, Maria May, Juan M. Perez-Saez, Maria R. Girotti, Santiago P. Mendez-Huergo, Betiana Pucci, Anibal H. Gil, Sergio P. Huernos, Guillermo H. Docena, Alicia M. Sambuelli, Marta A. Toscano, Gabriel A. Rabinovich, Karina Marino

Summary: The study reveals a glycosylation-dependent on-off circuit controlled by Galectin-1 (Gal1) and its glycosylated ligands which target activated CD8(+) T cells and shape cytokine profile to maintain intestinal homeostasis. In patients with inflammatory bowel disease, increased Gal1 is associated with dysregulated expression of glycosyltransferases C2GNT1 and ST6GAL1. This provides insights into the role of Gal1 and its glycosylated ligands in recalibrating T cell immunity to preserve intestinal homeostasis.

SCIENCE ADVANCES (2021)

Article Oncology

The Tn antigen promotes lung tumor growth by fostering immunosuppression and angiogenesis via interaction with Macrophage Galactose-type lectin 2 (MGL2)

Valeria da Costa, Sandra J. van Vliet, Paula Carasi, Sofia Frigerio, Pablo A. Garcia, Diego O. Croci, Maria Florencia Festari, Monique Costa, Mercedes Landeira, Santiago A. Rodriguez-Zraquia, Alejandro J. Cagnoni, Anabela M. Cutine, Gabriel A. Rabinovich, Eduardo Osinaga, Karina Marino, Teresa Freire

Summary: Tn antigen, originating from tumor cells, interacts with the MGL receptor to promote immunosuppression and angiogenesis, ultimately favoring tumor progression.

CANCER LETTERS (2021)

Article Cell Biology

Pathogenic mechanisms contributing to thrombocytopenia in patients with systemic lupus erythematosus

M. Constanza Baroni Pietto, Paola R. Lev, Ana C. Glembotsky, Cecilia P. Marin Oyarzun, Graciela Gomez, Victoria Collado, Cecilia Pisoni, Ramiro A. Gomez, Matias Grodzielski, Jacqueline Gonzalez, Karina Marino, Paula G. Heller, Nora P. Goette, Rosana F. Marta

Summary: The study found that systemic lupus erythematosus (SLE) patients with thrombocytopenia have abnormalities in platelet clearance and production, mainly due to apoptosis and desialylation leading to low platelet count. These abnormalities are more frequently observed in patients with thrombocytopenia and active disease.

PLATELETS (2022)

Review Biotechnology & Applied Microbiology

Targeting galectin-driven regulatory circuits in cancer and fibrosis

Karina V. Marino, Alejandro J. Cagnoni, Diego O. Croci, Gabriel A. Rabinovich

Summary: This article discusses the therapeutic relevance of galectins to cancer and fibrosis, and reviews the various strategies to target galectins and their progress in clinical trials.

NATURE REVIEWS DRUG DISCOVERY (2023)

暂无数据